Skip to main navigation Skip to search Skip to main content

SERENA-4: A randomized multicentre double blind phase III study of AZD9833 (an Oral SERD) plus palbociclib vs anastrozole plus palbociclib for the treatment of patients with estgrogen receptor-positive HER2 negative advanced breast cancer w

  • Sivapiragasam, Abirami (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/4/22 → 04/3/24

Funding

  • AstraZeneca Pharmaceuticals LP: $19,000.00